✓
Open
9 Jul 2025
✓
Close
11 Jul 2025
3
Allotment
—
✓
Listing
Wed, Jul 16, 2025
Price Band
₹115 to ₹123
Issue Size
22,41,000 shares (agg. up to ₹28 Cr)
Lot Size
1,000 Shares
Listing Date
Wed, Jul 16, 2025
Latest GMP
₹26
Est. Gain
21.14%
✦ AI Insight
GMP Trend
16-07-2025₹26Est. ₹149+21.14%
15-07-2025₹26Est. ₹149+21.14%
14-07-2025₹25Est. ₹148+20.33%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 130.28x |
Restated Financials (₹ Cr.)
| Period Ended | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 31.83 | 28.12 | 20.26 | 13.69 |
| Total Income | 6.21 | 25.61 | 15.84 | 7.19 |
| Profit After Tax | 1.32 | 4.33 | 1.36 | 1.06 |
| EBITDA | 1.93 | 6.16 | 2.55 | 1.52 |
| NET Worth | 12.04 | 10.72 | 6.39 | 1.99 |
| Reserves and Surplus | 5.77 | 4.45 | 5.61 | 1.29 |
| Total Borrowing | 7.83 | 7.26 | 6.82 | 5.25 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Influx Healthtech Ltd. | SME | ₹58.57 Cr | ₹96 | 13.04 | ₹126.20 | +31.46% | ₹283.70 |
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹289.00 |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹210.00 |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.51 |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹117.00 |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.55 |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,509.80 |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,647.10 |
| Akums Drugs & Pharmaceuticals Ltd. | Mainboard | ₹1,856.74 Cr | ₹679 | null | ₹796.25 | +17.27% | ₹736.60 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit | 6.00 |
| 2 | Funding the incremental working capital requirements of the Company | 13.00 |
| 3 | Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company | 1.00 |
| 4 | General Corporate Purposes | 3.95 |
| 5 | Issue Expenses | 3.61 |
| Total | 27.56 |
About Asston Pharmaceuticals IPO
Updated on Aug 5, 2026
Contact Details
Asston Pharmaceuticals Ltd. Address4th Floor, Office No.A-431 Balaji BhavanPlot No 42A Sector-11 CBD BelapurThane, Maharashtra, 400614+91 22 49731411info@asstonpharmaceuticals.comVisit Website